EFI
IBER.WS

EHP Funds Inc’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

EHP Funds Inc’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-110,325
Closed -$1K – 366
2022
Q4 		$1K Buy
110,325
+756
+0.7% +$24 ﹤0.01% 334
2022
Q3 		$11K Buy
109,569
+15,300
+16% +$1.64K ﹤0.01% 389
2022
Q2 		$8K Buy
+94,269
New +$16.3K ﹤0.01% 409

Other funds holding IBER.WS

LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

EHP Funds Inc's IBER.WS Position: Q1 2023 in Review

EHP Funds Inc sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 110,325 shares — an estimated $1K sold.

EHP Funds Inc first reported a position in IBER.WS in Q2 2022 and held it in 3 quarters. The position peaked at $11K in Q3 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

  • EHP Funds Inc reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • EHP Funds Inc sold 110,325 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1K.
  • EHP Funds Inc first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2022 and held it in 3 quarters.
  • EHP Funds Inc's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $11K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on EHP Funds Inc's 13F filing for Q1 2023, filed 15 May 2023.